Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Abiomed Inc (NASDAQ:ABMD)

100.37
Delayed Data
As of Jun 24
 -3.88 / -3.72%
Today’s Change
64.03
Today|||52-Week Range
110.68
+11.18%
Year-to-Date
No recent news for Abiomed Inc.

Today’s Trading

Previous close104.25
Today’s open99.00
Day’s range98.01 - 103.98
Volume4,664,903
Average volume (3 months)586,820
Market cap$4.3B
Dividend yield--
Data as of 4:00pm ET, 06/24/2016

Growth & Valuation

Earnings growth (last year)-67.92%
Earnings growth (this year)+32.81%
Earnings growth (next 5 years)+27.50%
Revenue growth (last year)+43.09%
P/E ratio118.1
Price/Sales12.92
Price/Book11.75

Competitors

 Today’s
change
Today’s
% change
WSTWest Pharmaceutical ...-2.91-3.84%
NUVANuVasive Inc-0.93-1.58%
IARTIntegra LifeSciences...-0.99-1.28%
MASIMasimo Corp-1.42-2.71%
Data as of 4:02pm ET, 06/24/2016

Financials

Next reporting dateJuly 28, 2016
EPS forecast (this quarter)$0.23
Annual revenue (last year)$329.5M
Annual profit (last year)$38.1M
Net profit margin11.58%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chairman, President &
Chief Executive Officer
Michael R. Minogue
Chief Operating Officer
David M. Weber
Corporate headquarters
Danvers, Massachusetts

Forecasts

Partner Offers

Search for Jobs